Polygenic determinants of Alzheimer's disease: Modulation of the risk by α-1-antichymotrypsin

Annals of the New York Academy of Sciences

Volumn 802, Issue , 1996, Pages 27-34

  DeKosky, Steven T ^a   Aston, Christopher E ^b   Kamboh, M Ilyas ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; GENE DOSAGE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR;

TRIXIS;

EID: 0030467521     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32595.x     Document Type: Conference Paper

References (23)

1. STRITTMATTER, W. J., A. M. SAUNDERS, D. E. SCHMECHEL, M. A. PERICAK-VANCE, J. ENGHILD, G. S. SALVESON & A. D. ROSES. 1993. Apolipoprotein E: High avidity binding by β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 1977-1981.
2. SAUNDERS, A. M., W. J. STRITTMATTER, D. SCHMECHEL, P. H. ST GEORGE-HYSLOP, M. A. PERICAK-VANCE, S. H. JOO, B. L. ROSI, J. F. GUSELLA, D. R. CRAPPER-MCLACHLAN, M. J. ALBERTS, C. HULETTE, B. CRAIN, D. GOLDGABER & A. D. ROSES. 1993. Association of apoliporotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
3. ROSES, A. D. 1995. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann. Neurol. 38: 6-14.
4. KAMBOH, M. I., D. K. SANGHERA, R. E. FERRELL & S. T. DEKOSKY. 1995. APOE ∈-associated Alzheimer's disease risk is modified by α1-antichymotrypsin polymorphism. Nature Genet. 10: 486-488.
5. ABRAHAM, C., D. SELKOE & H. POTTER. 1988. Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487-501.
6. ABRAHAM, C., T. SHIRAHAMA & H. POTTER. 1990. α1-Antichymotrypsin is associated solely with amyloid deposits containing the beta protein: Amyloid and cell localization of α1-antichymotrypsin. Neurobiol. Aging 11: 123-129.
7. PICKEN, M. M., M. LARRONDO-LILLO, F. CORIA, G. R. GALLO, M. L. SHELANSKI & B. FRANGIONE. 1990. Distribution of the protease inhibitor alpha-1-antichymotrypsin in cerebral and systemic amyloid. J. Neuropathol. Exper. Neurol. 49: 41-48.
8. ROZENMULLER, J. M., J. J. ABBINK, A. M. CAMP, F. C. SPAM, C. E. HACK & P. EIKELENBOOM. 1991. Distribution pattern and functional state of α-1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. Acta Neuropathol. 82: 200-207.
9. SHOJI, M., S. HIRAI, H. YAMAGUCHI, Y. HARIGAYA, K. ISHIGURO & E. MABSUBARA. 1991. Alpha-1-antichymotrypsin is present in diffuse senile plaques: A comparative study of beta protein and alpha-1-antichymotrypsin immunostaining in the Alzheimer brain. Am. J. Pathol. 138: 247-257.
10. MA, J., A. YEE, B. BREWER, JR., S. DAS & H. POTTER. 1994. Amyloid-associated proteins alpha-1-antichymotrypsin and apolipprotein E promote assembly of Alzheimer beta protein into filaments. Nature 372: 92-94.
11. APA. 1987. Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R. American Psychiatric Association, Washington, D.C.
12. MCKHANN, G., D. DRACHMAN, M. FOLSTEIN, R. KATZMAN, D. PRICE & E. M. STADLAN. 1984. Clinical diagnosis of Alzheimer's disease. Neurology 34: 939-944.
13. KAMBOH, M. I., C. E. ASTON & R. F. HAMMAN. 1995. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis 112: 145-159.
14. CAULEY, J., J. EICHNER, M. I. KAMBOH, R. FERRELL & L. KULLER. 1993. Apo E allele frequencies in younger (42-50) vs older (age 65-90) women. Genet. Epidemiol. 10: 27-34.
15. REBECK, G. W., T. T. PERLS, H. L. WEST, P. SODHI, L. A. LIPSITZ & B. T. HYMAN. 1994. Reduced apolipoprotein epsilon 4 frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 44: 1513-1516.
16. LOUHIJA, J., H. E. MIETTINEN, K. KONTULA, M. J. TIKKANEN & R. S. TILVIS. 1994. Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. Arterioscler. Thromb. 14: 1084-1089.
17. ROSES, A. D. 1994. Apoplipoprotein E affects the rate of Alzheimer disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 53: 429-437.
18. RANDALL, L. L. & S. J. S. HARDY. 1989. Unity in function in the absence of consequence in sequence: Role of leader peptides in export. Science 243: 1156-1159.
19. ALTSTEIL, L., B. LAWLOR, R. MOHS, J. SCHMEIDLER, A. DALTON, P. MEHTA & K. DAVIS. 1995. Elevated alpha-1-antichymotrypsin serum levels in a subset of nondemented first degree relatives of Alzheimer's disease patients. Dementia 6: 17-20.
20. MATSUBARA, E., S. HIRAI, M. AMARI, M. SHOJI, H. YAMAGUCHI, K. OKAMORO, K. ISHIGURO, Y. HARIGYA & K. WAKABAYASHI. 1990. Alpha-1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann. Neurol. 28: 561-567.
21. REBECK, G. W., J. S. REITER, D. K. STRICKLAND & B. T. HYMAN. 1993. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11: 575-580.
22. MAYEUX, R., R. OTTMAN, G. MAESTRE, C. NGAI, M.-X. TANG, H. GINSBERG, M. CHUN, B. TYCKO & M. SHELANSKI. 1995. Synergistic effects of traumatic head injury and apolipoprotein-E4 in patients with Alzheimer's disease. Neurology 45: 555-557.
23. DEKOSKY, S. T., M. FARLOW, D. K. SANGHERA, C. E. ASTON & M. I. KAMBOH. 1996. Modification of APOE ∈-mediated risk of Alzheimer's disease by alpha-1-antichymotrypsin in familial AD: Results from the Indiana Alzheimer Center National Cell Repository. Neurology 46: A418.